DAY ONE Trademark

Trademark Overview

On Wednesday, November 14, 2018, a trademark application was filed for DAY ONE with the United States Patent and Trademark Office. The USPTO has given the DAY ONE trademark a serial number of 88193220. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Hero Therapeutics, Inc.. The DAY ONE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
day one

General Information

Serial Number88193220
Word MarkDAY ONE
Filing DateWednesday, November 14, 2018
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6201030
Registration DateTuesday, November 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 1, 2018
Primary Code042
First Use Anywhere DateMonday, July 15, 2019
First Use In Commerce DateMonday, July 15, 2019

Trademark Owner History

Party NameDAY ONE BIOPHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameDAY ONE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameDAY ONE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameHero Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameHero Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Friday, September 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, October 15, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 14, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 23, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, September 4, 2020USE AMENDMENT FILED
Monday, September 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 4, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 18, 2020TTAB RELEASE CASE TO TRADEMARKS
Wednesday, March 18, 2020OPPOSITION TERMINATED NO. 999999
Wednesday, March 18, 2020OPPOSITION DISMISSED NO. 999999
Friday, August 9, 2019OPPOSITION INSTITUTED NO. 999999
Wednesday, May 22, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 11, 2019ASSIGNED TO LIE
Tuesday, February 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 19, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, February 19, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 19, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, February 19, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Saturday, December 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 17, 2018NEW APPLICATION ENTERED

Related Keywords

fields biotechnology pharmaceutical development research